-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Biomarin Pharmaceutical Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc Operating Income (Loss) for the quarter ending March 31, 2024 was $88.5 M, a 41.8% increase year-over-year.
- Biomarin Pharmaceutical Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was $184 M, a 147% increase year-over-year.
- Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2023 was $158 M, a 5.71% increase from 2022.
- Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2022 was $150 M.
- Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2021 was -$82.3 M, a 89.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)